PUT/INTUITIVE SURGICAL/500/0.01/21.03.25 Share Price

Warrant

DE000GG9NC01

Real-time BOERSE MUENCHEN 08:02:56 03/07/2024 BST
0.68 EUR -2.58% Intraday chart for PUT/INTUITIVE SURGICAL/500/0.01/21.03.25
Current month+8.05%
Date Price Change
03/07/24 0.68 -2.58%
02/07/24 0.698 -0.99%
01/07/24 0.705 +9.13%
28/06/24 0.646 -2.71%
27/06/24 0.664 0.00%

Real-time BOERSE MUENCHEN

Last update July 03, 2024 at 08:02 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying INTUITIVE SURGICAL, INC.
Issuer Goldman Sachs
WKN GG9NC0
ISINDE000GG9NC01
Date issued 13/06/2024
Strike 500 $
Maturity 21/03/2025 (262 Days)
Parity 100 : 1
Emission price 0.73
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.762
Lowest since issue 0.63
Delta-0.58x
Omega 3.442
Premium2.83x
Gearing5.96x
Moneyness 1.139
Difference Strike 61.19 $
Difference Strike %+12.24%
Spread 0.01
Spread %1.45%
Theoretical value 0.6840
Implied Volatility 32.22 %
Total Loss Probability 31.94 %
Intrinsic value 0.5694
Present value 0.1146
Break even 426.50 €
Theta-0x
Vega0.01x
Rho-0.02x

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
438.8 USD
Average target price
428.1 USD
Spread / Average Target
-2.44%
Consensus